Studies of effect and mechanism of chromium (trivalent) combined magnesium supplements on glucose tolerance and energy metabolism in insulin resistant crowd

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001843

Enrollment

Unknown

Registered

2011-12-29

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin resistance

Interventions

A:Placebo

B:Cr3+

C:Mg

D:Mg

Eligibility

Sex/Gender

All

Age

45 Years to 59 Years

Inclusion criteria

Inclusion criteria: people with insulin resistance, 45-59yrs.

Exclusion criteria

Exclusion criteria: Hypermagnesemia persons, cancer patients, and coronary heart diseasepatients, as well as patients taking various drugs for the treatment.

Design outcomes

Primary

Measure	Time frame
FBG;FIns;HOMA-IR;ISI;	—

Countries

China

Contacts

Public ContactDou Mei

littlefeidou@163.com+86 0532 82991503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026